SPY357.46+2.13 0.60%
DIA295.89+3.36 1.15%
IXIC11,880.63+25.66 0.22%

Cerevel Therapeutics Hldg Q3 EPS $(4.34) Up From $(5.16) YoY

Cerevel Therapeutics Hldg (NASDAQ:CERE) reported quarterly losses of $(4.34) per share. This is a 15.89 percent increase over losses of $(5.16) per share from the same period last year.

· 11/16/2020 06:32
Cerevel Therapeutics Hldg (NASDAQ:CERE) reported quarterly losses of $(4.34) per share. This is a 15.89 percent increase over losses of $(5.16) per share from the same period last year.